These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 34607710)

  • 1. Corrigendum to: Postoperative outcomes of primary and interval cytoreductive surgery for advanced ovarian cancer registered in the Dutch Gynecological Oncology Audit (DGOA) [Gynecologic Oncology Volume 162, Issue 2, August 2021, Pages 331-338].
    Tewarie NMSB; van Driel WJ; van Ham M; Wouters MW; Kruitwagen R;
    Gynecol Oncol; 2021 Dec; 163(3):615. PubMed ID: 34607710
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical auditing as an instrument to improve care for patients with ovarian cancer: The Dutch Gynecological Oncology Audit (DGOA).
    Baldewpersad Tewarie NMS; van Driel WJ; van Ham M; Wouters MW; Kruitwagen R;
    Eur J Surg Oncol; 2021 Jul; 47(7):1691-1697. PubMed ID: 33581966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corrigendum to "Combination effect of poly (ADP-ribose) polymerase inhibitor and DNA demethylating agents for treatment of epithelial ovarian cancer" [Gynecologic Oncology, Volume 165, Issue 2, May 2022, Pages 270-280].
    Shim JI; Ryu JY; Jeong SY; Cho YJ; Choi JJ; Hwang JR; Choi JY; Sa JK; Lee JW
    Gynecol Oncol; 2022 Aug; 166(2):370-371. PubMed ID: 35882469
    [No Abstract]   [Full Text] [Related]  

  • 4. Corrigendum to "Gemogenovatucel-T (Vigil) immunotherapy demonstrates clinical benefit in homologous recombination proficient (HRP) ovarian cancer" [Gynecologic Oncology Volume 161, Issue 3, June 2021, Pages 676-680].
    Rocconi RP; Monk BJ; Walter A; Herzog TJ; Galanis E; Manning L; Bognar E; Wallraven G; Stanbery L; Aaron P; Senzer N; Coleman RL; Nemunaitis J
    Gynecol Oncol; 2023 Feb; 169():173. PubMed ID: 36456375
    [No Abstract]   [Full Text] [Related]  

  • 5. Current clinical practice in cytoreductive surgery for advanced ovarian cancer: a European survey.
    Cibula D; Verheijen R; Lopes A; Dusek L;
    Int J Gynecol Cancer; 2011 Oct; 21(7):1219-24. PubMed ID: 21892096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementation of Enhanced Recovery After Surgery (ERAS) Pathways in Gynecologic Oncology. A NOGGO-AGO* survey of 144 Gynecological Departments in Germany.
    Muallem MZ; Dimitrova D; Pietzner K; Richter R; Feldheiser A; Scharfe I; Schmeil I; Hösl TM; Mustea A; Wimberger P; Burges A; Kimmig R; Sehouli J
    Anticancer Res; 2016 Aug; 36(8):4227-32. PubMed ID: 27466536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PROFAST: A randomised trial implementing enhanced recovery after surgery for highcomplexity advanced ovarian cancer surgery.
    Sánchez-Iglesias JL; Carbonell-Socias M; Pérez-Benavente MA; Monreal Clua S; Manrique-Muñoz S; García Gorriz M; Burgos-Peláez R; Segurola Gurrutxaga H; Pamies Serrano M; Pilar Gutiérrez-Barceló MD; Serrano-Castro S; Balcells-Farré MT; Pérez-Barragán C; Scaillet-Houberechts A; Cossio-Gil Y; Gil-Moreno A
    Eur J Cancer; 2020 Sep; 136():149-158. PubMed ID: 32688208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pre-operative assessment and post-operative outcomes of elderly women with gynecologic cancers, primary analysis of NRG CC-002: An NRG oncology group/gynecologic oncology group study.
    Ahmed A; Deng W; Tew W; Bender D; Mannel RS; Littell RD; DeNittis AS; Edelson M; Morgan M; Carlson J; Darus CJ; Fleury AC; Modesitt S; Olawaiye A; Evans A; Fleming GF
    Gynecol Oncol; 2018 Aug; 150(2):300-305. PubMed ID: 29807694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume stage III epithelial ovarian cancer: a Gynecologic Oncology Group study.
    Hoskins WJ; Bundy BN; Thigpen JT; Omura GA
    Gynecol Oncol; 1992 Nov; 47(2):159-66. PubMed ID: 1468693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incorporating robotic surgery into the management of ovarian cancer after neoadjuvant chemotherapy.
    Abitbol J; Gotlieb W; Zeng Z; Ramanakumar A; Kessous R; Kogan L; Pare-Miron V; Rombaldi M; Salvador S; Kucukyazici B; Brin S; How J; Lau S
    Int J Gynecol Cancer; 2019 Nov; 29(9):1341-1347. PubMed ID: 31601648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corrigendum to "Low-grade serous carcinoma (LGSC): A Canadian multicenter review of practice patterns and patient outcomes" [Gynecologic Oncology, Volume 157, Issue 1, April 2020, Pages 36-45].
    Scott SA; Fernandez ML; Kim H; Elit L; Nourmoussavi M; Glaze S; Roberts L; Offman SL; Rahimi K; Lytwyn A; Sur M; Gilks CB; Matheson K; Köbel M; Dawson A; Tinker AV; Kwon JS; Hoskins P; Santos JL; Cheung A; Provencher D; Carey MS;
    Gynecol Oncol; 2022 Nov; 167(2):399. PubMed ID: 37850594
    [No Abstract]   [Full Text] [Related]  

  • 12. A collaborative surgical approach to upper and lower abdominal cytoreductive surgery in ovarian cancer.
    Eng OS; Raoof M; Blakely AM; Yu X; Lee SJ; Han ES; Wakabayashi MT; Yuh B; Lee B; Dellinger TH
    J Surg Oncol; 2018 Jul; 118(1):121-126. PubMed ID: 29878375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corrigendum to 'Ribociclib plus fulvestrant for postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer in the phase III randomized MONALEESA-3 trial: updated overall survival': [Annals of Oncology Volume 32, Issue 8, August 2021, Pages 1015-1024].
    Slamon DJ; Neven P; Chia S; Jerusalem G; De Laurentiis M; Im S; Petrakova K; Valeria Bianchi G; Martín M; Nusch A; Sonke GS; De la Cruz-Merino L; Beck JT; Ji Y; Wang C; Deore U; Chakravartty A; Zarate JP; Taran T; Fasching PA
    Ann Oncol; 2021 Oct; 32(10):1307. PubMed ID: 34412950
    [No Abstract]   [Full Text] [Related]  

  • 14. [Up-date on cytoreductive surgery in the management of advanced ovarian cancer].
    Angioli R; Palaia I; Damiani P; Montera R; Benedetti Panici P
    Minerva Ginecol; 2006 Dec; 58(6):459-70. PubMed ID: 17108876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corrigendum to "Risk factors analysis of persistence, progression and recurrence in vaginal intraepithelial neoplasia" [Gynecologic Oncology, Volume 162, Issue 3, September 2021, Pages 584-589].
    Ao M; Zheng D; Wang J; Gu X; Xi M
    Gynecol Oncol; 2022 Aug; 166(2):369. PubMed ID: 35738916
    [No Abstract]   [Full Text] [Related]  

  • 16. International validation of Enhanced Recovery After Surgery Society guidelines on enhanced recovery for gynecologic surgery.
    Wijk L; Udumyan R; Pache B; Altman AD; Williams LL; Elias KM; McGee J; Wells T; Gramlich L; Holcomb K; Achtari C; Ljungqvist O; Dowdy SC; Nelson G
    Am J Obstet Gynecol; 2019 Sep; 221(3):237.e1-237.e11. PubMed ID: 31051119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of effectiveness of the PlasmaJet surgical device in the treatment of advanced stage ovarian cancer (PlaComOv-study): study protocol of a randomized controlled trial in the Netherlands.
    Nieuwenhuyzen-de Boer GM; Hofhuis W; Reesink-Peters N; Ewing-Graham PC; Schoots IG; Beltman JJ; Piek JMJ; Baalbergen A; Kooi GS; van Haaften A; van Huisseling H; Haans L; Dorman M; van Beekhuizen HJ
    BMC Cancer; 2019 Jan; 19(1):58. PubMed ID: 30642296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An audit of cytoreductive surgeries in ovarian cancer from a rural based cancer center.
    Dessai SB; Patil VM; Chakraborty S; Babu S; Bhattacharjee A; Nayanar S; Vikram S; Balasubramanian S
    Indian J Cancer; 2016; 53(2):284-287. PubMed ID: 28071628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corrigendum to "Surgical treatment of lung metastasis in patients with refractory gestational trophoblastic neoplasia: A retrospective study" [Gynecologic Oncology Volume 167, Issue 3, Oct 2022 Pages 37-41].
    Zhao L; Qin Y; Ma D; Liu H
    Gynecol Oncol; 2023 Feb; 169():172. PubMed ID: 36411086
    [No Abstract]   [Full Text] [Related]  

  • 20. Neoadjuvant chemotherapy combined with interval cytoreductive surgery in ovarian cancer.
    Li X; Du X
    J BUON; 2019; 24(5):2035-2040. PubMed ID: 31786872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.